Abstract
Abstract only
- Title
- A single arm, phase 2, multicenter, international trial of tisotumab vedotin (HuMax-TF-ADC) in previously treated, recurrent or metastatic cervical cancer
- Creators
- Robert L. Coleman - The University of Texas MD Anderson Cancer CenterNicole Concin - KU LeuvenThomas J. Herzog - University of CincinnatiLinn Lena Woelber - University Medical Center Hamburg-EppendorfMansoor Raza Mirza - Center for Clinical & Basic ResearchBradley J. Monk - University of ArizonaDavid Cibula - Charles UniversityDomenica Lorusso - Fondazione IRCCS Istituto Nazionale dei TumoriAntonio González-Martín - Clinica Universidad de NavarraKristian Windfeld - GenmabJeroen Lammerts van Bueren - Genmab, Utrecht, NetherlandsSigne Diness Vindeloev - GenmabReshma A. Rangwala - MSDIgnace Vergote - Universitair Ziekenhuis Leuven
- Publication Details
- Journal of clinical oncology, Vol.36(15_suppl), pp.TPS5601-TPS5601
- Identifiers
- 991005969068702656
- Academic Unit
- Obstetrics & Gynecology
- Language
- English
- Resource Type
- Journal article